Newer techniques in cancer chemotherapy.
D000911:Antibodies, Monoclonal / Q000276:immunology; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000378:metabolism; D001761:Bleomycin / Q000008:administration & dosage; D016026:Bone Marrow Transplantation; D002277:Carcinoma / Q000188:drug therapy; D002478:Cells, Cultured; D002648:Child; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000473:pathology; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000008:administration & dosage; D006499:Hepatic Artery / Q000378:metabolism; D006801:Humans; D006979:Hyperthermia, Induced; D007261:Infusions, Intra-Arterial; D002955:Leucovorin / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008466:Mechlorethamine / Q000008:administration & dosage; D008545:Melanoma / Q000188:drug therapy; D008577:Meningeal Neoplasms / Q000188:drug therapy; D008727:Methotrexate / Q000008:administration & dosage; D009369:Neoplasms / Q000188:drug therapy*; D012516:Osteosarcoma / Q000188:drug therapy; D010529:Peritoneal Cavity / Q000378:metabolism; D010994:Pleura / Q000378:metabolism
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D003561:Cytarabine; D001761:Bleomycin; D008466:Mechlorethamine; D004317:Doxorubicin; D002945:Cisplatin; D002955:Leucovorin; D005472:Fluorouracil; D008727:Methotrexate